Application of autovaccine preparation containing TGF beta 1
A technology of autologous vaccines and preparations, applied in the fields of immunology and animal vaccine manufacturing, which can solve the problems of incomplete inhibition of signaling pathways
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Embodiment 1: The preparation of an autologous vaccine preparation fused with the full amino acid sequence of TGF-β1 and LTB carrier protein, comprising the following steps:
[0039] 1.1 Construction of recombinant plasmid pET-TGF-LTB plasmid
[0040] 1.1.1 Download the amino acid sequences of TGFβ1 and LTB respectively from the genebank website. The amino acid sequence of TGFβ1 is shown in SEQ ID NO: 1, and the amino acid sequence of LTB is shown in SEQ ID NO: 2. In order to prevent the B cell epitope of TGFβ1 from being affected by LTB, A flexible linker sequence (GGGGSGGGGSGGGGS) is added between the LTB and TGFβ1 dinucleotide sequences. The sequence is shown in SEQ ID NO:3. Wherein LTB is located at the 5' end of the flexible linker sequence, and TGFβ1 is located at the 3' end of the flexible linker sequence. The sequence is LTB-GGGGSGGGGSGGGGS-TGFβ1. According to the preferred codon conversion of Escherichia coli into a nucleotide sequence, see SEQ ID NO: 4 for t...
Embodiment 2
[0051] Example 2: Preparation of an autologous vaccine preparation expressed in fusion with the universal helper T cell epitope (PADRE), tetanus toxin T cell epitope peptide and TGF-β1 whole protein sequence:
[0052] The amino acid sequence of the universal helper T cell epitope (PADRE) is shown in SEQ ID NO: 5, the amino acid sequence of the tetanus toxin T cell epitope peptide (TTE) is shown in SEQ ID NO: 6, and the amino acid sequence of the constructed fusion protein is: PADRE- TTE-GGGGSGGGGSGGGGS-TGFβ1, the amino acid sequence is optimized according to the codons of E. coli, and the nucleotide sequence of the fusion protein is obtained by the method of whole gene synthesis, and cloned into the expression vector, and the expression strain is transformed to obtain the fusion protein. The specific preparation scheme is carried out with reference to Example 1 and "Molecular Cloning Experiment Guide".
Embodiment 3
[0053] Example 3: Effect of TGFβ1 autovaccine preparation on the number of CD4+CD25+ regulatory T cells in mice.
[0054] The prepared LTB-TGF or PARDE-TGF fusion protein was used to immunize mice for the second time, in which the fusion protein was immunized with complete Freund's adjuvant for the first time, and the fusion protein was immunized with incomplete Freund's adjuvant for the second time. mouse. The time interval between the second immunization was 15 days, and CD4 was measured 15 days after the second immunization + CD25 + The number and distribution of regulatory T cells. The reagents used were FITC rat anti-mouse CD4 monoclonal antibody and PE rat anti-mouse CD25 monoclonal antibody from eBioscience, USA, and CD4 was measured by BD FACSCaliburTM flow cytometer. + CD25 + The number and distribution of regulatory T cells. The results showed that autologous vaccine formulations were able to significantly reduce the number of regulatory T cells.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com